Sunday 16 May - Pre-Conference Day
16.00 - 18.00
|
Exhibition Set-Up
|
19.30 - 21.00
|
Speaker's Reception
|
Monday 17 May - Conference Day One
| 08.00 |
Registration |
| |
Morning Session Chair:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
, Scientific Update, UK |
| 08.55 |
Opening Remarks
|
| 09.00 |
Dr Trevor Calkins, SAFC-Pharma, USA Safety and Engineering Hurdles for HPAPI Manufacturing |
| 09.45 |
Dr Gilda Gasparini, AM Tech, UK Solving Flow Chemistry Problems with CSTRs |
| 10.30 |
Coffee and Exhibition |
| 11.15 |
Dr Charles Gordon, Pfizer, UK Development and Scale Up of a Commercial Process to Imagablin |
| 12.00 |
Dr Johannes de Vries, DSM Research, The Netherlands Use of Centrifugal Contactor Separators for Extractive Separation of Racemates using Catalytic amounts of a Chiral Host Compound |
| 12.45 |
Lunch and Exhibition
|
| |
Afternoon Session Chair: Dr Johannes de Vries, DSM Research, The Netherlands |
| 14.00 |
Mr Lee Griffiths, AstraZeneca, UK Use of PAT to Facilitate Operation of ‘Fit for Purpose’ Processes in Early Pilot Manufacture |
| 14.45 |
Dr Wim Dermaut, Janssen Pharmaceutica NV, Belgium Safety Aspects of a Cyanamide Reaction: About Modelling, Adiabatic Testing and Reflux Barriers |
| 15.30 |
Coffee and Exhibition
|
| 16.15 |
Mr Martin Jonsson, Alfa Laval Tumba, Sweden and Dr Anna Stenemyr, AstraZeneca, Sweden Flow Chemistry Development and Scale-Up Alfa Laval ART® Plate Reactors Case Study of a Grignard Reaction Performed in Batch and in Continuous Flow
|
| 17.00 |
Mr Daniel Rivero, Uquifa SA, Spain Water Distillation Under High Vacuum
|
| 17.45 |
Welcome Reception
|